Global Breast Cancer Treatment Market to Grow at a CAGR of 10.1% by 2031

Published January 30, 2023


The ‘Global Breast Cancer Treatment Market Size, Report and Forecast 2023-2031’, by Expert Market Research, gives an extensive outlook of the global breast cancer treatment market, assessing the market based on its segments like diagnosis, therapy, indication, distribution channel, and major regions.

Breast Cancer Treatment Market Size, Share, Price Trends, Industry Report, Key Players, Major Segments, and Forecast

The key highlights of the report include:

Market Overview (2016-2031)

• Historical Market Size (2022): USD 20.64 Billion
• Forecast CAGR (2023-2031): 10.1%
• Forecast Market Size (2031): USD 49.08 Billion

Global breast cancer treatment is driven by the growing demand and use of therapeutics and diagnostics. The treatment of breast cancer has different categories based on the stage, extent to which it has spread in the body, size etc. There are different therapies being used to treat breast cancer like radiation therapy, chemotherapy, Hormone therapy. Apart from these therapies, surgery is mostly used to treat breast cancer. In chemotherapy, the cancerous cells are destroyed with the use of drugs. After surgery, this is the most widely used method to get rid of cancer and stop its recurrence.

Get a Free Sample Report with Table of Contents:

The demand for the global breast cancer treatment market is also expected to grow in the forecasted period with the significant advancements in the discovery of many therapeutic products to treat breast cancer. There has been continuous research and development work in the pharmaceutical sector for the development of various breast cancer treatment strategies which in turn is helping the market to grow substantially.

Breast Cancer Treatment Industry Definition and Major Segments

The abnormal growth of cell in and around the breast is called Breast cancer. The former can be treated using various methodologies like chemotherapy, biological therapy, surgical treatments, radiation therapy, hormonal therapy. With these treatments, the cancerous lumps are removed and spread of cancerous cells to other organs is prevented. The global breast cancer market is segmented as follows:

Based on diagnosis, the market Breakup is segmented into:

• Imaging
• Biopsy
• Genomic Tests
• Blood Tests
• Others

Based on Therapy, the market is segmented into:

  •  Targeted Therapy
    •  Abemaciclib
    •  Ado-Trastuzumab Emtansine
    •  Everolimus
    •  Trastuzumab
    •  Ribociclib
    •  Palbociclib
    •  Pertuzumab
    •  Olaparib
    •  Others
  •  Hormonal Therapy
    •  Selective Estrogen Receptor Modulators (SERMs)
    •  Aromatase Inhibitors
    •  Estrogen Receptor Downregulators (ERDs)

• Chemotherapy
• Immunotherapy
• Others

Based on indication, the market is bifurcated into:

• Invasive Ductal Carcinoma
• Invasive Lobular Carcinoma
• Others

Based on distribution channel, the market is segmented into:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Based on region, the market is segmented into:

  • North America
    • United States of America
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others

Read Full Report with Table of Contents:

Breast Cancer Treatment Market Trends

The global cancer treatment market is driven by the increasing cases of breast cancer in developing as well as developed countries. A recent study in 2021 of Cancer Australia, by the age of 85, the risk of breast cancer has been estimated to be one case per fifteen individuals. Increasing research and development in this field is further attributed to the growth of the global cancer treatment market. Many key players in the pharmaceutical sector are coming together to develop various therapies to treat breast cancer. Lately, Arvinas and Pfizer have collaboratively developed ARV-471 which is an investigational therapy. It has a significant effect for the management of breast cancer.

The global breast cancer treatment market is expected to propel in North America as a region in the forecasted period due to the increasing number of cases in the region as well as the growing awareness amongst people on the methods to treat the disease.

Key Market Players

The major players in the market are Mylan N.V (Viatris Inc.), AstraZeneca, Celltrion Inc, Bristol-Myers Squibb Company, Fresenius Kabi AG, Eisai Co., Ltd., Baxter, GSK plc, Pfizer Inc., Halozyme, Inc, and Novartis AG. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

The report studies the latest updates in the market, along with their impact across the market. It also analysis the market demand, together with its price and demand indicators. The report also tracks the market on the bases of SWOT and Porter’s Five Forces Models.

More Reports:

Incontinence Products Market:

Patent Analytics Market:

Neuroendocrine Tumours Treatment Market:       

Hyperphosphatemia Therapeutics Market:

Emergency Medical Services (EMS) Vehicle Market:

Asia Pacific Water and Wastewater Treatment Market:

About Us:

Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.

EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.

Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.

Media Contact

Company Name: Claight Corporation
Contact Person: Sophia Grace, Business Consultant
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA